Evidence map›Paper›PMID 42069649›Full record

ArticleBMC chemistry2026

Design of experiments and bioanalytical LC-MS/MS method for analysis of melatonin and tasimelteon in rat brain homogenate with whiteness assessment.

Serkan Levent, Abeer Elriş, Hazal Avcı, Saniye Özcan, Nafiz Öncü Can

Abstract read
In one paragraph

Article in BMC chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Serkan LeventDepartment of Analytical Chemistry, Faculty of Pharmacy, Anadolu University, Yunusemre Campus, 26470, Eskisehir, Turkey. [email protected].ORCID http://orcid.org/0000-0003-3692-163X
Abeer ElrişDepartment of Analytical Chemistry, Graduate School, Anadolu University, Yunusemre Campus, 26470, Eskisehir, Türkiye.ORCID http://orcid.org/0000-0001-8467-478X
Hazal AvcıDepartment of Analytical Chemistry, Faculty of Pharmacy, Anadolu University, Yunusemre Campus, 26470, Eskisehir, Turkey.ORCID http://orcid.org/0009-0000-8479-3615
Saniye ÖzcanDepartment of Analytical Chemistry, Faculty of Pharmacy, Anadolu University, Yunusemre Campus, 26470, Eskisehir, Turkey.ORCID http://orcid.org/0000-0002-5492-0457
Nafiz Öncü CanDepartment of Analytical Chemistry, Faculty of Pharmacy, Anadolu University, Yunusemre Campus, 26470, Eskisehir, Turkey.ORCID http://orcid.org/0000-0003-0280-518X

Funding

Anadolu Üniversitesi BGT-2024-2639
6 · The paper itself

Abstract

Sleep disorders include a range of common problems that affect the quality of sleep at night and, as a result, impact an individual's daily functioning. Treatment protocols vary from over-the-counter products to regulated pharmaceuticals. Melatonin and Tasimelteon are two compounds utilized for severe to moderate sleeping disorders. This study developed and validated a sensitive, simple bioanalytical LC-MS/MS method for the measurement of Melatonin and Tasimelteon in spiked rat brain tissue. Chromatographic analyses were conducted in isocratic mode, with Citalopram selected as an appropriate internal standard. The Supelco Ascentis® Express Phenyl-Hexyl column was used for the stationary phase, and the mobile phase comprised 0.2% formic acid in a mixture of acetonitrile and water (65:35, v/v). A response surface methodology is applied. The Box-Behnken design was used to optimize the influence of three independent factors (acetonitrile%, formic acid%, and flow rate (mL/min)) on the response. The study focused on finding the most significant factors influencing chromatographic separation, namely the resolution between Tasimelteon and Melatonin, as well as the tailing factors of both. Statistical analysis of variance provided the optimal conditions for separating the substances as well as the most influential factors. Validation of the analytical method was conducted in accordance with the International Council for Harmonization guideline M10 related to bioanalytical method validation. The method validated was precise and linear in 55.00-1650 (ng/mL) and 20-600 (ng/mL) for the Melatonin and Tasimelteon, respectively. The validated method's lower limit of quantification values was 55 and 20 ng/mL for Melatonin and Tasimelteon, respectively. For Melatonin, intraday accuracy (recovery, %) ranged from 96.53% to 102.68%, and precision (expressed as relative standard deviation) ranged from 0.26% to 0.96%. And inter-day accuracy ranged from 96.58% to 103.08%, and inter-day precision ranged from 0.33% to 3.55%. Intraday accuracy results for Tasimelteon 99.61%-103. 75% precision results were in the range 0.23%-0.93%; additionally, inter-day accuracy was 99.37-103.87%, and the precision range was 1.04-2.11%. The total run time was 3 min, with retention time for Melatonin and Tasimelteon at 1.9 and 2.5 min, respectively, achieving effective chromatographic separation under optimum conditions. The Red Green Blue 12 score for whiteness was determined to be 79.2%.

Indexed as

DoELC-MS/MSMelatoninTasimelteonValidation

Identifiers

PMID42069649
PMCPMC13312675

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.